Suriclone: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|Overview of the pharmaceutical drug Suriclone}} | |||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 477002123 | |||
| image = Suriclone.svg | |||
| image_size = 200px | |||
| image_alt = Structural formula of Suriclone | |||
}} | |||
'''Suriclone''' is a pharmaceutical drug belonging to the class of [[cyclopyrrolones]], which are known for their [[anxiolytic]] and [[hypnotic]] properties. It is primarily used in the treatment of [[anxiety]] disorders and [[insomnia]]. | |||
Suriclone | ==Pharmacology== | ||
Suriclone acts as a [[GABA_A receptor]] [[agonist]], enhancing the inhibitory effects of [[gamma-aminobutyric acid]] (GABA) in the central nervous system. This action results in its calming effects, making it effective for reducing anxiety and inducing sleep. | |||
== | ==Mechanism of Action== | ||
[[File:Suriclone.svg|thumb|right|200px|Structural formula of Suriclone]] | |||
Suriclone binds to the [[benzodiazepine]] site on the GABA_A receptor, which increases the frequency of [[chloride ion]] channel opening events. This leads to hyperpolarization of the neuron and a decrease in neuronal excitability. | |||
Suriclone is | ==Clinical Use== | ||
Suriclone is prescribed for the management of anxiety disorders and short-term treatment of insomnia. It is known for its rapid onset of action and relatively short half-life, which minimizes the risk of [[daytime sedation]]. | |||
== Side Effects == | ==Side Effects== | ||
Common side effects of Suriclone include [[drowsiness]], [[dizziness]], and [[headache]]. In some cases, patients may experience [[paradoxical reactions]] such as increased anxiety or [[agitation]]. | |||
==Contraindications== | |||
Suriclone should not be used in individuals with a history of [[substance abuse]], severe [[respiratory depression]], or [[myasthenia gravis]]. Caution is advised in patients with [[hepatic impairment]]. | |||
== | ==Related pages== | ||
* [[Cyclopyrrolone]] | * [[Cyclopyrrolone]] | ||
* [[ | * [[GABA_A receptor]] | ||
* [[Anxiolytic]] | |||
* [[Hypnotic]] | |||
[[Category:Anxiolytics]] | [[Category:Anxiolytics]] | ||
[[Category: | [[Category:Hypnotics]] | ||
[[Category:Cyclopyrrolones]] | [[Category:Cyclopyrrolones]] | ||
Latest revision as of 03:30, 13 February 2025
Overview of the pharmaceutical drug Suriclone
| Suriclone | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Suriclone is a pharmaceutical drug belonging to the class of cyclopyrrolones, which are known for their anxiolytic and hypnotic properties. It is primarily used in the treatment of anxiety disorders and insomnia.
Pharmacology[edit]
Suriclone acts as a GABA_A receptor agonist, enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) in the central nervous system. This action results in its calming effects, making it effective for reducing anxiety and inducing sleep.
Mechanism of Action[edit]
Suriclone binds to the benzodiazepine site on the GABA_A receptor, which increases the frequency of chloride ion channel opening events. This leads to hyperpolarization of the neuron and a decrease in neuronal excitability.
Clinical Use[edit]
Suriclone is prescribed for the management of anxiety disorders and short-term treatment of insomnia. It is known for its rapid onset of action and relatively short half-life, which minimizes the risk of daytime sedation.
Side Effects[edit]
Common side effects of Suriclone include drowsiness, dizziness, and headache. In some cases, patients may experience paradoxical reactions such as increased anxiety or agitation.
Contraindications[edit]
Suriclone should not be used in individuals with a history of substance abuse, severe respiratory depression, or myasthenia gravis. Caution is advised in patients with hepatic impairment.
